港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

药明合联

54.900

+2.1003.98%

成交量：708.81万

成交额：3.85亿

市值：692.29亿

市盈率：42.30

高：55.850

开：53.550

低：51.900

收：52.800

52周最高：85.500

52周最低：38.050

股本：12.61亿

香港流通股本：12.61亿

量比：1.27

换手率：0.56%

股息：- -

股息率：- -

每股收益(LYR):1.298

净资产收益率：17.05%

总资产收益率：8.60%

市净率：5.57

市盈率(LYR):42.30

市销率: 10.05

数据加载中...

总览公司新闻资讯公告

药明合联(02268)出现大手卖出150万股，成交价$54.9，涉资8.235千万

阿斯达克财经

异动解读｜药明合联盘中上涨3.22%，受托人斥资3.27亿港元回购570万股提振信心

药明合联(02268)：专业受托人于公开市场上购买570.2万股

药明合联受托人斥资3.265亿港元，于5月19日至29日期间以均价57.3港元回购570万股

港股收评：恒指跌1.27%险守25000点科指跌0.39% 科网股低迷黄金股普跌智谱逆势涨超13%

异动解读｜药明合联盘中下跌3.14%，密集回购未能扭转板块持续抛压

异动解读｜药明合联盘中下跌3.04%，回购利好未能抵消板块持续抛压

【券商聚焦】国泰海通维持药明合联(02268)“增持”评级指其回购彰显长期信心

异动解读｜药明合联盘中下跌3.14%，报56.05港元

异动解读｜药明合联盘中下跌3.03%，报55.95港元

港股异动 | 药明合联(02268)再涨超6% 拟斥最多1亿美元回购股份公司盈利可见性增强

异动解读｜药明合联盘中上涨3.17%，公司拟斥资最多1亿美元回购股份

《股市简讯》中国药明合联劲涨6.6%，拟斥至多1亿美元回购股份

生物医药板块盘初普涨药明合联(02268)涨5.24%、百济神州(06160)涨2.17%

药明合联拟动用最多1亿美元的内部资金购买股份

创新药概念走软药明合联(02268)领跌5.57% 机构成仍看好以创新为主医药科技主线

《大行》摩通：医保目录调整加速创新药商业化首选信达生物(01801.HK)药明康德(02359.HK)药明合联(02268.HK)科伦博泰(06990.HK)

阿斯达克财经

【券商聚焦】国泰海通：前瞻布局下一代自免药物企业有望实现估值重塑

【券商聚焦】中国银河：医药行业进入复苏周期 CXO板块景气度较高

药明合联4月股份变动月报：增发177万余股

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02268/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02268","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":54.9,"timestamp":1780042106004,"preClose":52.8,"halted":0,"volume":7088067,"delay":0,"changeRate":0.0397727272727273,"floatShares":1261000000,"shares":1261000000,"eps":1.297722840346079,"marketStatus":"休市中","change":2.1,"latestTime":"05-29 16:08:26","open":53.55,"high":55.85,"low":51.9,"amount":384775616,"amplitude":0.074811,"askPrice":54.95,"askSize":10000,"bidPrice":54.9,"bidSize":10500,"shortable":3,"etf":0,"ttmEps":1.2957959519439506,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780277400000},"marketStatusCode":7,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":52.8,"openAndCloseTimeList":[[1780018200000,1780027200000],[1780030800000,1780041600000]],"volumeRatio":1.2683857831540812,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","floatShares":1261000000,"roa":"8.60%","roe":"17.05%","lyrEps":1.297723,"volumeRatio":1.2683857831540812,"shares":1261000000,"dividePrice":0,"high":55.85,"amplitude":0.074811,"preClose":52.8,"low":51.9,"week52Low":38.05,"pbRate":"5.57","psRate":"10.05","week52High":85.5,"institutionHeld":0,"latestPrice":54.9,"committee":0.02439,"eps":1.297722840346079,"divideRate":0,"volume":7088067,"delay":0,"ttmEps":1.2957959519439506,"open":53.55,"prevYearClose":60.75,"prevWeekClose":57.3,"prevMonthClose":58.9,"prevQuarterClose":58.2,"fiveDayClose":55.75,"twentyDayClose":58.55,"sixtyDayClose":63.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02268\",params:#limit:5,,,undefined,":[{"date":"2026-04-29","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777426200000,"name":null,"time":"","dateTimestamp":1777392000000,"actualEps":null},{"date":"2026-03-23","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-18","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-20","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724117400000,"name":null,"time":"","dateTimestamp":1724083200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02268\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02268\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.35,"buy":0.65,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.65,"analysts":20,"updateTime":1776182400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02268\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02268","date":"2026-05-29","current":42.367118,"percent":0.10306,"low":30.568632,"twenty":43.728165,"median":57.509324,"eighty":70.694281,"high":153.052589,"avg":62.498955,"sd":25.793246,"marketCap":69207452491},"quantilePoints":[{"date":"2023-11-17","current":130.035431,"twenty":0.435785,"median":0.444801,"eighty":2.787891,"marketCap":32996488000},{"date":"2023-11-24","current":133.579843,"twenty":0.435785,"median":0.444801,"eighty":2.810425,"marketCap":34174934000},{"date":"2023-12-01","current":147.707211,"twenty":0.435785,"median":0.444801,"eighty":2.852893,"marketCap":37945961200},{"date":"2023-12-08","current":132.646927,"twenty":0.435785,"median":0.444801,"eighty":2.935117,"marketCap":33939244800},{"date":"2023-12-15","current":138.75437,"twenty":0.435785,"median":0.444801,"eighty":3.039251,"marketCap":35706913800},{"date":"2023-12-22","current":153.052589,"twenty":0.435785,"median":0.444801,"eighty":3.172504,"marketCap":39360096400},{"date":"2023-12-29","current":145.85951,"twenty":0.435785,"median":0.444801,"eighty":3.326638,"marketCap":37710272000},{"date":"2024-01-05","current":142.305018,"twenty":0.435785,"median":0.444801,"eighty":3.599996,"marketCap":36531826000},{"date":"2024-01-12","current":138.558869,"twenty":0.435785,"median":0.444801,"eighty":3.622774,"marketCap":35589069200},{"date":"2024-01-19","current":141.046625,"twenty":0.435785,"median":0.444801,"eighty":3.635946,"marketCap":36178292200},{"date":"2024-01-26","current":116.23004,"twenty":0.435785,"median":0.444801,"eighty":3.642902,"marketCap":29696839200},{"date":"2024-02-02","current":82.111439,"twenty":0.435785,"median":0.444801,"eighty":3.654128,"marketCap":20952769880},{"date":"2024-02-09","current":67.278987,"twenty":0.435825,"median":0.445043,"eighty":3.68657,"marketCap":17252449440},{"date":"2024-02-16","current":66.713097,"twenty":0.435798,"median":0.44487,"eighty":3.704054,"marketCap":17111035920},{"date":"2024-02-23","current":82.124312,"twenty":0.435798,"median":0.44487,"eighty":3.728385,"marketCap":20952769880},{"date":"2024-03-01","current":86.135235,"twenty":0.435812,"median":0.444939,"eighty":3.767614,"marketCap":21989802360},{"date":"2024-03-08","current":96.662972,"twenty":0.435812,"median":0.444939,"eighty":3.804363,"marketCap":24688443700},{"date":"2024-03-15","current":72.134287,"twenty":0.435812,"median":0.444939,"eighty":3.87411,"marketCap":18407326520},{"date":"2024-03-22","current":82.739174,"twenty":0.435812,"median":0.444939,"eighty":3.907844,"marketCap":21094183400},{"date":"2024-03-28","current":70.236298,"twenty":0.435812,"median":0.444939,"eighty":3.924107,"marketCap":21565561800},{"date":"2024-04-05","current":69.514463,"twenty":0.435772,"median":0.444721,"eighty":3.932321,"marketCap":21329872600},{"date":"2024-04-12","current":72.929575,"twenty":0.435785,"median":0.444801,"eighty":3.970214,"marketCap":22390474000},{"date":"2024-04-19","current":66.691535,"twenty":0.435785,"median":0.444801,"eighty":4.01279,"marketCap":20457822560},{"date":"2024-04-26","current":78.851628,"twenty":0.435812,"median":0.444939,"eighty":62.837086,"marketCap":24158143000},{"date":"2024-05-03","current":79.483533,"twenty":0.435812,"median":0.444939,"eighty":66.70016,"marketCap":24334909900},{"date":"2024-05-10","current":73.189732,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":22461180760},{"date":"2024-05-17","current":65.221538,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19986444160},{"date":"2024-05-24","current":58.278715,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17818103520},{"date":"2024-05-31","current":59.948577,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":18347300940},{"date":"2024-06-07","current":58.299117,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17820354960},{"date":"2024-06-14","current":64.156468,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19592809620},{"date":"2024-06-21","current":70.500097,"twenty":0.435812,"median":0.444939,"eighty":69.593748,"marketCap":21485024730},{"date":"2024-06-28","current":68.013259,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":20718557850},{"date":"2024-07-05","current":61.893714,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":18850294830},{"date":"2024-07-12","current":63.530585,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":19377240810},{"date":"2024-07-19","current":56.933019,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17365265250},{"date":"2024-07-26","current":56.800526,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17389217340},{"date":"2024-08-02","current":69.358964,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":21221551740},{"date":"2024-08-09","current":72.710245,"twenty":0.435812,"median":0.444939,"eighty":70.597189,"marketCap":22395204150},{"date":"2024-08-16","current":74.003491,"twenty":0.435812,"median":0.444939,"eighty":70.930659,"marketCap":22802389680},{"date":"2024-08-23","current":35.050376,"twenty":0.435812,"median":0.44524,"eighty":71.736965,"marketCap":22742129354},{"date":"2024-08-30","current":36.779427,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":24024219892},{"date":"2024-09-06","current":36.193339,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":23652773101},{"date":"2024-09-13","current":36.950123,"twenty":0.435812,"median":0.445611,"eighty":71.736965,"marketCap":24084130665},{"date":"2024-09-20","current":36.912594,"twenty":0.435798,"median":0.445732,"eighty":71.812082,"marketCap":24203952211},{"date":"2024-09-27","current":41.596291,"twenty":0.435798,"median":0.446064,"eighty":71.812082,"marketCap":27439133942},{"date":"2024-10-04","current":49.267448,"twenty":0.435798,"median":0.446181,"eighty":71.812082,"marketCap":32351817312},{"date":"2024-10-10","current":43.61955,"twenty":0.435812,"median":0.446472,"eighty":71.736965,"marketCap":28457617080},{"date":"2024-10-18","current":43.201999,"twenty":0.435798,"median":0.446694,"eighty":71.812082,"marketCap":28038241670},{"date":"2024-10-25","current":43.020102,"twenty":0.435798,"median":0.446852,"eighty":71.812082,"marketCap":27918420124},{"date":"2024-11-01","current":41.699543,"twenty":0.435798,"median":0.446999,"eighty":71.812082,"marketCap":27079669305},{"date":"2024-11-08","current":47.130705,"twenty":0.435852,"median":0.447279,"eighty":71.812082,"marketCap":30374761809},{"date":"2024-11-15","current":46.740281,"twenty":0.435852,"median":0.44753,"eighty":71.812082,"marketCap":29895475627},{"date":"2024-11-22","current":46.01742,"twenty":0.435852,"median":0.447785,"eighty":71.812082,"marketCap":29416189444},{"date":"2024-11-29","current":51.670123,"twenty":0.435852,"median":0.448371,"eighty":71.812082,"marketCap":33010835812},{"date":"2024-12-06","current":54.048034,"twenty":0.435852,"median":0.449445,"eighty":71.812082,"marketCap":34448694360},{"date":"2024-12-13","current":58.707371,"twenty":0.435852,"median":0.45138,"eighty":71.812082,"marketCap":37384322227},{"date":"2024-12-20","current":60.54506,"twenty":0.435852,"median":35.016583,"eighty":71.812082,"marketCap":38342894592},{"date":"2024-12-27","current":58.22519,"twenty":0.435852,"median":35.863906,"eighty":71.812082,"marketCap":36845125272},{"date":"2025-01-03","current":57.033249,"twenty":0.435852,"median":36.241161,"eighty":71.812082,"marketCap":36126195998},{"date":"2025-01-10","current":62.66188,"twenty":0.435852,"median":36.730689,"eighty":71.812082,"marketCap":39541110048},{"date":"2025-01-17","current":54.642634,"twenty":0.436361,"median":37.212991,"eighty":71.812082,"marketCap":34508605132},{"date":"2025-01-24","current":54.868028,"twenty":0.436606,"median":39.470644,"eighty":71.812082,"marketCap":34868069769},{"date":"2025-01-28","current":52.331181,"twenty":0.436643,"median":41.238065,"eighty":71.736965,"marketCap":33430211222},{"date":"2025-02-07","current":57.910706,"twenty":0.437089,"median":42.380717,"eighty":71.8872,"marketCap":36785214499},{"date":"2025-02-14","current":56.82028,"twenty":0.437089,"median":43.020102,"eighty":71.8872,"marketCap":36006374452},{"date":"2025-02-21","current":70.802488,"twenty":0.437089,"median":44.139364,"eighty":71.8872,"marketCap":45112811918},{"date":"2025-02-28","current":60.65941,"twenty":0.437089,"median":45.078416,"eighty":71.8872,"marketCap":38522626910},{"date":"2025-03-07","current":67.088057,"twenty":0.437583,"median":46.607669,"eighty":71.962317,"marketCap":42776291779},{"date":"2025-03-14","current":72.98104,"twenty":0.438098,"median":47.703312,"eighty":71.990989,"marketCap":46550670465},{"date":"2025-03-21","current":80.244903,"twenty":0.438098,"median":49.592986,"eighty":72.978175,"marketCap":51163799971},{"date":"2025-03-28","current":47.906694,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":54840613248},{"date":"2025-04-03","current":43.121995,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":49380552191},{"date":"2025-04-11","current":35.581021,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":40380451549},{"date":"2025-04-17","current":33.597127,"twenty":0.4381,"median":49.700845,"eighty":72.980467,"marketCap":38220427395},{"date":"2025-04-25","current":39.226609,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44663120338},{"date":"2025-05-02","current":40.829264,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":46586700218},{"date":"2025-05-09","current":38.818219,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44603008467},{"date":"2025-05-16","current":39.608151,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":45882474676},{"date":"2025-05-23","current":38.196121,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44379117053},{"date":"2025-05-30","current":41.172242,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48047309655},{"date":"2025-06-06","current":42.866418,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":50152010328},{"date":"2025-06-13","current":46.041552,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":53888090995},{"date":"2025-06-20","current":41.240748,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48174509918},{"date":"2025-06-27","current":40.971553,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":47994081042},{"date":"2025-07-04","current":46.000985,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":53888090995},{"date":"2025-07-11","current":47.288014,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":55339986740},{"date":"2025-07-18","current":50.925924,"twenty":0.438098,"median":50.569275,"eighty":72.98104,"marketCap":59550637905},{"date":"2025-07-25","current":57.660678,"twenty":0.438098,"median":51.683826,"eighty":72.98104,"marketCap":67671179437},{"date":"2025-08-01","current":57.245588,"twenty":0.438098,"median":52.545804,"eighty":72.98104,"marketCap":66768897045},{"date":"2025-08-08","current":57.73965,"twenty":0.43811,"median":53.257543,"eighty":72.98104,"marketCap":67513611340},{"date":"2025-08-15","current":64.222783,"twenty":31.309336,"median":54.856958,"eighty":72.98104,"marketCap":74981664691},{"date":"2025-08-22","current":48.130228,"twenty":34.419063,"median":54.952855,"eighty":72.98104,"marketCap":69501077151},{"date":"2025-08-29","current":46.988345,"twenty":35.581021,"median":54.952855,"eighty":72.98104,"marketCap":68176099944},{"date":"2025-09-05","current":54.370406,"twenty":36.186031,"median":55.113399,"eighty":72.98104,"marketCap":78808670381},{"date":"2025-09-12","current":57.034752,"twenty":36.596757,"median":55.50873,"eighty":72.98104,"marketCap":82819396110},{"date":"2025-09-19","current":59.571504,"twenty":36.911418,"median":56.000464,"eighty":72.98104,"marketCap":86441593568},{"date":"2025-09-26","current":63.204858,"twenty":37.279949,"median":56.495601,"eighty":72.98104,"marketCap":91475834102},{"date":"2025-10-03","current":72.025865,"twenty":37.670679,"median":56.699916,"eighty":72.980467,"marketCap":104491187679},{"date":"2025-10-10","current":60.90024,"twenty":38.189538,"median":56.97042,"eighty":72.98104,"marketCap":88221995708},{"date":"2025-10-17","current":57.936353,"twenty":38.732076,"median":57.121577,"eighty":72.98104,"marketCap":83863080123},{"date":"2025-10-24","current":59.821834,"twenty":39.226609,"median":57.526112,"eighty":72.98104,"marketCap":86623810506},{"date":"2025-10-31","current":63.630196,"twenty":39.774995,"median":57.92353,"eighty":72.98104,"marketCap":92275860553},{"date":"2025-11-07","current":58.827143,"twenty":40.354886,"median":58.251953,"eighty":72.98104,"marketCap":85257233036},{"date":"2025-11-14","current":59.953959,"twenty":41.172242,"median":58.455089,"eighty":72.98104,"marketCap":87136525462},{"date":"2025-11-21","current":57.356344,"twenty":41.596291,"median":58.554061,"eighty":72.98104,"marketCap":83322340564},{"date":"2025-11-28","current":56.291024,"twenty":42.018405,"median":58.564991,"eighty":72.98104,"marketCap":82071768197},{"date":"2025-12-05","current":57.95451,"twenty":42.42494,"median":58.564991,"eighty":72.98104,"marketCap":84642388897},{"date":"2025-12-12","current":56.819112,"twenty":42.866418,"median":58.860686,"eighty":72.98104,"marketCap":83137635317},{"date":"2025-12-19","current":59.902097,"twenty":43.024716,"median":58.930609,"eighty":72.98104,"marketCap":87855221510},{"date":"2025-12-24","current":53.787136,"twenty":43.211711,"median":58.930609,"eighty":72.98104,"marketCap":79132453088},{"date":"2026-01-02","current":52.131715,"twenty":43.875774,"median":58.940897,"eighty":73.022778,"marketCap":76998826280},{"date":"2026-01-09","current":60.097118,"twenty":44.079539,"median":58.920321,"eighty":72.979321,"marketCap":88984788643},{"date":"2026-01-16","current":59.868148,"twenty":44.329264,"median":59.011667,"eighty":72.978748,"marketCap":88933823858},{"date":"2026-01-23","current":58.064858,"twenty":44.542103,"median":59.011667,"eighty":72.978748,"marketCap":86172293688},{"date":"2026-01-30","current":52.991062,"twenty":44.673253,"median":58.945496,"eighty":72.939295,"marketCap":79001941874},{"date":"2026-02-06","current":53.067413,"twenty":44.72485,"median":58.907275,"eighty":72.769063,"marketCap":79316440050},{"date":"2026-02-13","current":54.647287,"twenty":44.764796,"median":58.707371,"eighty":72.713983,"marketCap":82146923636},{"date":"2026-02-20","current":54.893728,"twenty":44.79956,"median":58.576126,"eighty":72.595053,"marketCap":82398522177},{"date":"2026-02-27","current":52.350133,"twenty":44.938454,"median":58.531174,"eighty":72.112603,"marketCap":79442239320},{"date":"2026-03-06","current":49.767005,"twenty":45.116803,"median":58.469542,"eighty":72.01889,"marketCap":74913465582},{"date":"2026-03-13","current":45.00506,"twenty":45.116803,"median":58.377121,"eighty":71.985255,"marketCap":68057405340},{"date":"2026-03-20","current":44.215816,"twenty":45.114658,"median":58.350601,"eighty":71.8872,"marketCap":66610713729},{"date":"2026-03-27","current":44.200592,"twenty":44.738431,"median":58.251953,"eighty":71.510989,"marketCap":74095770324},{"date":"2026-04-02","current":45.669591,"twenty":44.705679,"median":58.178024,"eighty":71.208025,"marketCap":76926253910},{"date":"2026-04-10","current":46.69114,"twenty":44.720057,"median":58.083986,"eighty":71.116562,"marketCap":79253540415},{"date":"2026-04-17","current":44.791912,"twenty":44.756008,"median":58.021448,"eighty":71.047996,"marketCap":76061715137},{"date":"2026-04-24","current":43.082404,"twenty":44.540659,"median":57.95451,"eighty":71.023309,"marketCap":73162925662},{"date":"2026-04-30","current":43.702031,"twenty":44.455544,"median":57.910706,"eighty":70.948458,"marketCap":74234217425},{"date":"2026-05-08","current":41.406601,"twenty":44.305836,"median":57.763162,"eighty":70.834479,"marketCap":70579222000},{"date":"2026-05-15","current":40.413023,"twenty":44.11658,"median":57.660678,"eighty":70.789938,"marketCap":69066810100},{"date":"2026-05-22","current":42.353477,"twenty":43.947372,"median":57.58604,"eighty":70.759799,"marketCap":72217668225},{"date":"2026-05-29","current":40.447429,"twenty":43.728165,"median":57.509324,"eighty":70.694281,"marketCap":69207452491}],"updateTime":1780115185822},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02268\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2639625522","title":"药明合联(02268)出现大手卖出150万股，成交价$54.9，涉资8.235千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2639625522","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639625522?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 16:08","pubTimestamp":1780042080,"startTime":"0","endTime":"0","summary":"[大手成交]药明合联(02268)在下午04:08出现大手卖出，成交量为150万，成交价为港币$54.9，涉资8.235千万。至目前为止，股价升3.977%，今日最高价为$55.85，而最低价为$51.9，总成交量为704.607万股，总成交金额港币$3.825亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2605297752/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2605297752/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","02268","SG9999014674.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102753792","title":"异动解读｜药明合联盘中上涨3.22%，受托人斥资3.27亿港元回购570万股提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1102753792","media":"行情直击","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102753792?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 09:43","pubTimestamp":1780019003,"startTime":"0","endTime":"0","summary":"5月29日，药明合联盘中上涨3.22%，报53.75港元/股，成交额3277.35万港元，此前连续多个交易日走弱后出现反弹。消息面上，公司当日公告披露，专业受托人于5月19日至29日期间在公开市场购买570.2万股股份，占已发行股份总数约0.45%，总代价约3.27亿港元，平均购买价每股57.3港元，资金全部来自公司自有财务资源。此外，母公司药明生物此前宣布不超过4亿美元回购计划，药明系合计回购规模达5亿美元。板块内药明康德涨4.3%、药明生物涨2.29%，整体情绪回暖。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639614545","title":"药明合联(02268)：专业受托人于公开市场上购买570.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639614545","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639614545?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 06:37","pubTimestamp":1780007830,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明合联(02268)发布公告，于2026年5月19日至2026年5月29日期间，专业受托人在公开市场上购买570.2万股股份(相当于本公告日期已发行股份总数约0.45%)，总代价约为3.27亿港元，平均购买价为每股57.3港元。股份购买的资金全数由本公司的自有财务资源拨付。所购买股份目前由受托人根据本公司股份计划的规则以及本公司与受托人订立的信托契约条款持有。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","BK1141","SG9999014674.SGD","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183789229","title":"药明合联受托人斥资3.265亿港元，于5月19日至29日期间以均价57.3港元回购570万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1183789229","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183789229?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 06:32","pubTimestamp":1780007536,"startTime":"0","endTime":"0","summary":"药明合联的受托人于2026年5月19日至29日期间，在公开市场进行了一系列股份回购。数据显示，此次回购行动共涉及570万股股份，总耗资约3.265亿港元。经计算，平均每股回购价格约为57.3港元。这一举措通常被视为公司对自身未来发展抱有信心的信号，也可能旨在提升股东价值或优化资本结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638663070","title":"港股收评：恒指跌1.27%险守25000点 科指跌0.39% 科网股低迷 黄金股普跌 智谱逆势涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638663070","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638663070?lang=zh_cn&edition=fundamental","pubTime":"2026-05-28 16:08","pubTimestamp":1779955680,"startTime":"0","endTime":"0","summary":"　　5月28日消息，港股三大指数集体下跌。截至收盘，恒生指数跌1.27%，报25006.16，恒生科技指数跌0.39%，国企指数跌1.17%。盘面上，科网股跌多涨少，美团跌超5%，阿里巴巴、腾讯、哔哩哔哩、百度跌超2%，联想涨超3%；黄金股普跌，中国黄金国际跌超6%；创新药概念股持续走弱，药明合联跌超7%；AI应用股部分上涨，智谱涨超13%。　　AI应用股部分上涨，智谱涨超13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-05-28/doc-inhzmtwq8653089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02268","03115","LU2488822045.USD","07226","83115","BK1141","03423","09088","03088","BK1544","03067","MCHmain","SG9999001093.SGD","02513","03419","02800","HSI","09115","BK1117","07552","HHImain","07200","07500","SG9999014674.SGD","HSTECH","03417","03032","03037","82800","02099","02833","BK1198","513600","SG9999003461.SGD","JINFF","02837","BK1592","03033","07300","09067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187958849","title":"异动解读｜药明合联盘中下跌3.14%，密集回购未能扭转板块持续抛压","url":"https://stock-news.laohu8.com/highlight/detail?id=1187958849","media":"行情直击","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187958849?lang=zh_cn&edition=fundamental","pubTime":"2026-05-28 09:46","pubTimestamp":1779932784,"startTime":"0","endTime":"0","summary":"5月28日，药明合联盘中下跌3.14%，报55.4港元/股，成交额2810.37万港元，连续多个交易日走弱。消息面上，公司此前公告拟动用最多1亿美元内部资金在公开市场回购股份，母公司药明生物亦宣布不超过4亿美元回购计划，合计回购规模达5亿美元。然而密集回购仍未能有效提振市场信心，药明系个股整体承压，药明康德跌3.52%、药明生物跌2.73%。国泰海通维持公司\"增持\"评级，目标价84.38港元，看好ADC赛道增长前景。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110755377","title":"异动解读｜药明合联盘中下跌3.04%，回购利好未能抵消板块持续抛压","url":"https://stock-news.laohu8.com/highlight/detail?id=1110755377","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110755377?lang=zh_cn&edition=fundamental","pubTime":"2026-05-27 10:58","pubTimestamp":1779850685,"startTime":"0","endTime":"0","summary":"5月27日，药明合联盘中下跌3.04%，报55.75港元/股，成交额8616.81万港元。消息面上，公司此前公告拟动用最多1亿美元内部资金在公开市场回购股份，母公司药明生物亦于5月26日宣布不超过4亿美元的回购计划，合计回购规模达5亿美元。然而密集回购未能有效提振股价，板块整体承压明显。生命科学工具和服务行业中，药明生物跌1.22%、药明康德跌1.55%、晶泰控股跌3.11%。国泰海通维持公司\"增持\"评级，目标价84.38港元，看好ADC赛道增长前景。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638001595","title":"【券商聚焦】国泰海通维持药明合联(02268)“增持”评级 指其回购彰显长期信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2638001595","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638001595?lang=zh_cn&edition=fundamental","pubTime":"2026-05-26 14:41","pubTimestamp":1779777692,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国泰海通证券发布研报指，药明合联 拟使用最高1亿美元内部资金开展股份回购，彰显长期发展信心。公司现金储备充裕，为资本开支提供坚实基础。国泰海通看好ADC等新模态药物带动下对CDMO需求的提升及公司业绩的持续兑现，维持“增持”评级，目标价84.38港元。2025年，在金额超过10亿美元的ADC并购交易中，50%的被收购方是药明合联客户。未完成订单约14.89亿美元，同比增长50.3%；新签合同价值13.3亿美元，同比增长41%。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1982186","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","02611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153962782","title":"异动解读｜药明合联盘中下跌3.14%，报56.05港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1153962782","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153962782?lang=zh_cn&edition=fundamental","pubTime":"2026-05-26 10:09","pubTimestamp":1779761383,"startTime":"0","endTime":"0","summary":"5月26日，药明合联盘中下跌3.14%，报56.05港元/股，成交额6748.74万港元。药明合联所在的生命科学工具和服务行业中，个股表现分化，其中药明生物涨3.73%，金斯瑞生物科技涨0.08%，药明康德跌2.0%，晶泰控股跌2.39%，英矽智能跌3.77%。药明合联生物技术有限公司是一家主要从事提供抗体偶联药物（ADC）及其他生物偶联药物的全面合同研究、开发及制造组织（CRDMO）服务的投资控股公司，业务覆盖国内市场、北美、欧洲和世界其他地区。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175372022","title":"异动解读｜药明合联盘中下跌3.03%，报55.95港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175372022","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175372022?lang=zh_cn&edition=fundamental","pubTime":"2026-05-21 15:36","pubTimestamp":1779348968,"startTime":"0","endTime":"0","summary":"5月21日，药明合联盘中下跌3.03%，报55.95港元/股，成交额1.48亿港元。药明合联所在的生命科学工具和服务行业中，个股表现分化，其中昭衍新药涨6.06%，药明康德涨1.62%，晶泰控股涨0.76%，药明生物跌1.03%，英矽智能跌4.78%。药明合联是一家主要从事抗体偶联药物（ADC）及其他生物偶联药物的全面合同研究、开发及制造组织（CRDMO）服务的投资控股公司，业务覆盖国内市场、北美、欧洲和世界其他地区。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636589432","title":"港股异动 | 药明合联(02268)再涨超6% 拟斥最多1亿美元回购股份 公司盈利可见性增强","url":"https://stock-news.laohu8.com/highlight/detail?id=2636589432","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636589432?lang=zh_cn&edition=fundamental","pubTime":"2026-05-20 10:40","pubTimestamp":1779244809,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明合联再涨超6%，截至发稿，涨6.35%，报58.65港元，成交额1.69亿港元。消息面上，药明合联日前公布，公司已议决动用最多1亿美元的内部资金，委托专业受托人在公开市场购买公司股份。值得一提的是，截至2025年末，药明合联未完成订单总量为14.89亿美元，同比增长50.3%，充沛的未完成订单为未来业绩提供保障。该行认为这增强公司的盈利可见性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","LU2488822045.USD","SG9999014674.SGD","BK4585","BK4588","VXUS","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103975812","title":"异动解读｜药明合联盘中上涨3.17%，公司拟斥资最多1亿美元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1103975812","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103975812?lang=zh_cn&edition=fundamental","pubTime":"2026-05-20 10:06","pubTimestamp":1779242811,"startTime":"0","endTime":"0","summary":"5月20日，药明合联盘中上涨3.17%，报56.9港元/股，成交额5503.44万港元。消息面上，药明合联于5月18日公告，公司已议决动用最多1亿美元内部资金，委任专业受托人按当时市价在公开市场购买公司股份。公司明确表示，当前股份交易价格并未反映其内在价值或实际业务前景，认为此时进行回购系良机。董事会认为集团目前财务资源充裕，能以内部资源实施回购的同时维持稳固财务状况。此外，生物医药板块近期整体表现偏强，叠加回购利好持续发酵，推动股价延续上行。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636886973","title":"《股市简讯》中国药明合联劲涨6.6%，拟斥至多1亿美元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2636886973","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636886973?lang=zh_cn&edition=fundamental","pubTime":"2026-05-19 10:35","pubTimestamp":1779158114,"startTime":"0","endTime":"0","summary":"《股市简讯》中国药明合联劲涨6.6%，拟斥至多1亿美元回购股份* 从药明生物2269.HK分拆上市的中国生物偶联药物代工研发生产商--药明合联2268.HK周二早盘一度劲升6.6%。* 该公司上日公告称，已议决动用最多1亿美元的内部资金回购股份。* 药明合联今年迄今跌8.1%，同期恒生指数.HSI上扬0.7%。* 恒生生物科技指数.HSBIO盘中一度升1.8%。（完）更多股市简讯请点选CN-CMN-HOT (发稿 徐凯文；审校 张喜良) ((kaiwen.xu@thomsonreuters.com))","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nL4T41W07X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636885146","title":"生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636885146","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636885146?lang=zh_cn&edition=fundamental","pubTime":"2026-05-19 09:46","pubTimestamp":1779155169,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药板块盘初普涨，截至发稿，药明合联 涨5.24%，科伦博泰生物涨4.01%，百济神州涨2.17%，诺诚健华涨2.00%，药明生物涨1.58%，康诺亚-B涨1.35%，金斯瑞生物科技涨1.12%。消息面上，中邮证券研究表示，26年有望迎来BD和重点项目数据读出的双重催化，国产创新药全球性竞争力提升逻辑不断强化。建议关注确定性高、BD预期扰动相对小的标的。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1688375341.USD","06160","LU0708995583.HKD","161726","LU0516422440.USD","09969","BK1589","LU0456846285.SGD","LU1719994722.HKD","LU0417516738.SGD","LU0417516902.SGD","LU0348825331.USD","LU0823426308.USD","LU0052750758.USD","LU1770034418.SGD","688235","02269","XBI","06990","LU0039217434.USD","LU0516422366.SGD","LU1242518931.SGD","SG9999002562.SGD","LU1303224171.USD","LU0307460666.USD","02268","LU1251922891.USD","LU3063872942.SGD","BK4588","IE00B0JY6N72.USD","BK1161","01548","LU0181495838.USD","ONC","399441","HK0000306701.USD","LU0359201612.USD","BK4581","BK1576","BK1141","BK1574","BK1583","BK1588","HK0000320264.USD","LU0588546209.SGD","SG9999014674.SGD","LU0043850808.USD","LU0359202008.SGD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636742670","title":"药明合联拟动用最多1亿美元的内部资金购买股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2636742670","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636742670?lang=zh_cn&edition=fundamental","pubTime":"2026-05-18 22:40","pubTimestamp":1779115256,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明合联(02268)公布，公司已议决其动用最多1亿美元的内部资金，以供公司不时为公司股份计划委任的专业受托人按当时市价在公开市场上购买公司股份。公司认为，股份目前的交易价格并未反映其内在价值或公司的实际业务前景，此乃公司进行建议股份购买的良机。董事会认为，集团目前的财务资源能使其以内部资源实施建议股份购买，同时为集团营运的持续增长维持稳固的财务状况。","market":"us","thumbnail":"https://static.tigerbbs.com/9194f9fb43dce1485f0258ebbb901e84","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9194f9fb43dce1485f0258ebbb901e84"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443163.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明合联拟动用最多1亿美元的内部资金购买股份","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999014674.SGD","BK1141","LU2488822045.USD","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636048086","title":"创新药概念走软 药明合联(02268)领跌5.57% 机构成仍看好以创新为主医药科技主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2636048086","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636048086?lang=zh_cn&edition=fundamental","pubTime":"2026-05-18 10:09","pubTimestamp":1779070152,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念整体走软，截至发稿，药明合联 跌5.57%，亚盛医药-B跌5.50%，四环医药跌4.55%，康方生物跌4.49%，歌礼制药-B跌4.36%，同源康医药-B跌4.31%，康诺亚-B跌4.24%，荣昌生物跌4.14%。展望2026年，该机构继续看好以创新为主的医药科技主线，重点关注创新药、脑机接口、AI医疗、手术机器人等，同时建议布局2026年行业有望迎来反转的老龄化及院外消费，关注估值较低的麻药、血制品、中药等。","market":"us","thumbnail":"https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981521","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0540923850.HKD","BK1161","01672","LU1969619763.USD","LU0348766576.USD","LU0348767384.USD","LU1961090484.USD","06855","159992","LU2328871848.SGD","LU0417516738.SGD","LU0348783233.USD","LU0417516571.SGD","IE00B5MMRT66.SGD","LU2476274308.USD","LU0634319403.HKD","LU2488822045.USD","SG9999014674.SGD","BK1141","02162","BK1593","09939","159938","LU0348735423.USD","LU0561508036.HKD","IE00BPRC5H50.USD","LU2778985437.USD","LU2399975544.HKD","09926","BK1587","IE00B543WZ88.USD","LU0348827113.USD","LU2476274720.SGD","02268","BK1574","BK1600","LU0348784397.USD","BK1515","00460","02410","BK1583","LU1720050803.USD","BK1191","06978","LU1794554557.SGD","LU0348825331.USD","LU0417516902.SGD","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634636272","title":"《大行》摩通：医保目录调整加速创新药商业化  首选信达生物(01801.HK)药明康德(02359.HK)药明合联(02268.HK)科伦博泰(06990.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634636272","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634636272?lang=zh_cn&edition=fundamental","pubTime":"2026-05-12 11:49","pubTimestamp":1778557740,"startTime":"0","endTime":"0","summary":"报告指出，商业保险至国家医保目录的桥接路径正式确立，验证了许多创新药公司一直追求的双重清单策略。目前被商业保险覆盖但未纳入国家医保目录的药物，因零售价过往超出医保谈判的接受范围，新规对此类药物尤其有意义。摩根大通重申对信达生物、科伦博泰、药明康德及药明合联的正面看法，并将其列为行业首选股。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1524013/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1524013/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2045819591.USD","HK0000165453.HKD","02359","LU0196878994.USD","LU2097828557.USD","BK1161","BK1589","LU1046422090.SGD","LU2488822045.USD","LU1934453819.USD","LU1808992512.USD","LU1770034418.SGD","LU0348766576.USD","06990","159992","LU1997244956.HKD","LU2097828631.EUR","02268","LU1251922891.USD","LU1969619763.USD","LU2242644610.SGD","LU0348767384.USD","LU2097828805.USD","LU1719994722.HKD","LU2125910500.SGD","LU0456842615.SGD","LU2097828714.EUR","LU2495084118.USD","01801","BK1574","BK1583","BK1576","LU1997245094.SGD","BK1141","LU1979443071.USD","LU2097828474.EUR","LU0708995583.HKD","LU1303224171.USD","BK0216","LU0320764599.SGD","06978","LU0455707207.USD","LU2328871848.SGD","LU0052750758.USD","LU1997245177.USD","SG9999014674.SGD","LU0502904849.HKD","603259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633203104","title":"【券商聚焦】 国泰海通：前瞻布局下一代自免药物企业有望实现估值重塑","url":"https://stock-news.laohu8.com/highlight/detail?id=2633203104","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633203104?lang=zh_cn&edition=fundamental","pubTime":"2026-05-08 09:29","pubTimestamp":1778203751,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国泰海通证券研究认为，自免行业正进入由技术代际更迭带来的3.0时代。随着口服小分子、自免TCE、细胞因子双重/多重阻断抗体、小核酸药物等突破性疗法进入数据兑现期，迭代路径将逐渐清晰，前瞻布局下一代自免药物的企业有望实现估值重塑。该机构对行业维持“增持”评级，建议关注自免赛道潜在大品种：CM512、SHR-1139、CM336、GR1803、Nomelcitinib、奥布替尼、HSK47388、ATG-201、AK139、GB261、QX031N、IBI3002等。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980887","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2476274308.USD","06160","LU1770034418.SGD","BK0012","LU0307460666.USD","BK0028","01099","LU2778985437.USD","01789","BK1617","IE00B5MMRT66.SGD","02611","LU0348784397.USD","LU0348825331.USD","02367","LU0417516571.SGD","LU0561508036.HKD","09688","BK1191","LU0348827113.USD","LU0348766576.USD","LU1794554557.SGD","01530","LU1961090484.USD","LU0417516738.SGD","02196","LU1303224171.USD","SG9999014674.SGD","BK1583","09926","LU2328871848.SGD","BK1515","LU0634319403.HKD","LU0348735423.USD","SG9999004311.SGD","02228","06821","LU0348767384.USD","LU0348783233.USD","LU0417516902.SGD","BK1588","601211","03933","LU1251922891.USD","LU2399975544.HKD","BK1100","BK1574","02268","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633687104","title":"【券商聚焦】中国银河：医药行业进入复苏周期 CXO板块景气度较高","url":"https://stock-news.laohu8.com/highlight/detail?id=2633687104","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633687104?lang=zh_cn&edition=fundamental","pubTime":"2026-05-08 09:00","pubTimestamp":1778202049,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中国银河证券表示，2025年医药行业上市公司营业收入增长0.4%，归母净利润增长3.9%，扣非净利润下降4.1%，2026年一季度营业收入增长1.1%，归母净利润下降3.2%，扣非净利润增长2.0%。2025全年医药行业收入端小幅微增，主要系医保控费趋严，仿制药、耗材等集采常态化开展导致行业承压。2026年一季度创新药产业链高景气度延续，收入增幅扩大、非经常性损益占比下降，行业整体经营盈利能力提升，进入复苏上行周期。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980878","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","LU1961090484.USD","LU1251922891.USD","02367","LU1969619763.USD","LU0348783233.USD","09926","BK1207","BK1583","LU0417516738.SGD","09688","LU1794554557.SGD","BK0276","601881","BK1500","LU0640798160.USD","06821","LU0417516571.SGD","BK1588","LU2476274720.SGD","LU0561508036.HKD","HK0000165453.HKD","LU0588546209.SGD","02228","BK1197","LU0307460666.USD","BK1585","LU2778985437.USD","LU0634319403.HKD","BK1141","BK1593","LU0417516902.SGD","LU1719994722.HKD","LU1303224171.USD","LU2328871848.SGD","IE00BPRC5H50.USD","02268","06881","LU0348735423.USD","01099","02196","01530","BK1161","03933","BK0188","LU0348766576.USD","LU2488822045.USD","CXO","LU0348767384.USD","01789"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185863319","title":"药明合联4月股份变动月报：增发177万余股","url":"https://stock-news.laohu8.com/highlight/detail?id=1185863319","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185863319?lang=zh_cn&edition=fundamental","pubTime":"2026-05-06 17:56","pubTimestamp":1778061364,"startTime":"0","endTime":"0","summary":"药明合联生物技术有限公司于2026年5月6日发布了截至2026年4月30日的证券变动月报。公告显示，公司4月末法定股本维持在100亿股，面值0.00005美元，总注册股本约50万美元，与上月底持平。公司截至4月30日的已发行普通股数从上月底的1,258,835,897股增至1,260,609,335股，期间增发1,773,438股。根据公告，新增发行股份主要来自若干购股权行使。其中包括2021年和2023年多期首次公开发售前购股权计划，共计行使股份1,773,438股，对应行权所得资金合计人民币4,449,564.86元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}